EUCTR2004-003929-27-IT进行中（未招募）不适用
Randomized, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20-mg od, for inhibition of atherosclerosis progression assessed by IVUS (IntraVascular UltraSounds), in overweight patients with clustering risk factors
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Randomized, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20-mg od, for inhibition of atherosclerosis progression assessed by carotid artery intima-media thickness (CIMT), in overweight patients with additional risk factors - AUDITOROverweight patients with additional risk factors. Atherosclerosis progression assessed by carotid artery intima-media thickness (CIMT).MedDRA version: 7.1Level: LLTClassification code 10003601EUCTR2005-001612-49-GBSanofi-Synthelabo Recherche600
进行中（未招募）
1 期
Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobulin (IgPro20)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)MedDRA version: 18.1Level: PTClassification code 10061811Term: Demyelinating polyneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-003448-28-EECSL Behring GmbH350
进行中（未招募）
1 期
Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobulin (IgPro20)EUCTR2011-003448-28-ITCSL BEHRING GMBH250
进行中（未招募）
1 期
Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobulin (IgPro20)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)MedDRA version: 19.0Level: PTClassification code 10061811Term: Demyelinating polyneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-003448-28-PLCSL Behring GmbH350
进行中（未招募）
1 期
Chronic inflammatory demyelinating polyneuropathy (CIDP) and treatment with subcutaneous immunoglobulin (IgPro20)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)MedDRA version: 18.1Level: PTClassification code 10061811Term: Demyelinating polyneuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-003448-28-CZCSL Behring GmbH350